3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Endotoxemia: new trials by email Literature Review of Endotoxemia trials Research Report on Endotoxemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass Bifidobacterium animalis ssp. lactis 420, Polydextrose, Placebo - Obesity, Hyperglycemia | Phase 2 | Completed | Danisco | 225 | 2013-11-01 | 2016-02-02 |
| Lipid Infusion in Dialysis Patients With Endotoxemia Lipidose, Placebo - Fatigue, End Stage Renal Disease (ESRD) | Phase 2 | Completed | Sepsicure | 22 | 2007-08-01 | 2011-09-20 |
| CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) CTI-01 (ethyl pyruvate) - Coronary Disease, Heart Valve Diseases | Phase 2 | Terminated | Critical Therapeutics | 150 | 2005-04-01 | 2006-03-17 |
| A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis E5564 - Sepsis, Shock, Septic | Phase 2 | Completed | Eisai Inc. | 300 | 2001-10-01 | 2005-12-12 |
Coronary Disease (1) · Fatigue (1) · Heart Valve Diseases (1) · Hyperglycemia (1) · Infections (1) · Inflammation (1) · Insulin Resistance (1) · Kidney Failure, Chronic (1) · Obesity (1) · Sepsis (1) · Shock (1) · Shock, Septic (1) · Systemic Inflammatory Response Syndrome (1)
Bacteremia (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Toxemia (4) · Infections (3) · Inflammation (3) · Sepsis (3) · Systemic Inflammatory Response Syndrome (3) · Signs and Symptoms (2) · Body Weight (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
20-aldehyde leukotriene B4 (1) · E5564 (1) · ethyl pyruvate (1) · microcrystalline cellulose (1) · polydextrose (1)
Critical Therapeutics (1) · Danisco (1) · Eisai Inc. (1) · Sepsicure (1)
United States (3) · Finland (1)
Aila Rissanen, MD (1) · Alec Wittek, M.D. (1) · Roxana Bologa, MD (1) · Walter Newman, Ph.D. (1)